Cannabis & Cannabinoid Research Poster Session
Some posters are available digitally, please download the poster by clicking on the poster title.
Please note the poster sessions are not eligible for Section 1 credits. Learning from poster presentations may be claimed as a scanning activity under Section 2. You may claim 0.5 credits per poster with a documented learning outcome: https://www.royalcollege.ca/rcsite/cpd/moc-
Poster Presentations
| PRESENTER NAME | POSTER TITLE | PRESENTATION DATE | POSTER NUMBER |
| Shifrin, Alexandra | CannabisUse and Motives in Emerging Adulthood: A Feasibility Study Using Ecological Momentary Assessment | Day 1 April 21 | 101 |
| Drupals, Megan | The Effect of Prenatal THC and CBD Exposure on Behaviour in the Adult Rodent | Day 1 April 21 | 102 |
| Filippini, Helena | Effects of Delta-9-tetrahydrocannabinol in pain and disease stages of osteoarthritis in mice. | Day 1 April 21 | 103 |
| Hume, Catherine | Investigating the "Munchies;" Effects of Tetrahydrocannabinol Vapour Inhalation on Rodent Feeding Behaviours and Homeostatic Appetite-Regulating Pathways | Day 1 April 21 | 104 |
| Huynh, Odile | Examining the Anti-neoplastic Properties of Cannabinoid Formulations Against Breast Cancer | Day 1 April 21 | 105 |
| Kim, Jay | Impact of the Mouse Estrus Cycle on CP55,940-Induced Behavioral Outcomes | Day 1 April 21 | 106 |
| Lightfoot, Savannah | Investigating the Effects of Acute THC Vapour Exposure on Stress Reactivity and Fear Conditioning | Day 1 April 21 | 107 |
| Mielnik, Catharine | The Effect of MJN110 (MAGL Inhibitor) in Hyperdopaminergic States: Implications for 2-AG Modulation in Psychosis | Day 1 April 21 | 108 |
| Mohamed, Kawthar | Evaluation of Novel Bitopic Ligands at the Type 2 Cannabinoid Receptor | Day 1 April 21 | 109 |
| Powlowski, Pavel | Understanding the Effects of Cannabinoids on Mitochondrial Function | Day 1 April 21 | 110 |
| Santos, Alexandra | In Vitro Anti-Seizure Effects of Cannabinoids and Terpenes | Day 1 April 21 | 111 |
| Yi (William), Yang | Preparation of A Key Intermediate in the Total Synthesis of Novel cis-CBD Stereoisomers | Day 1 April 21 | 112 |
| Zagzoog, Ayat | Pharmacokinetic Characterization of a Novel Cannabinoid Receptor Allosteric Modulator: GAT1102 | Day 1 April 21 | 113 |
| Zain, Maham | Bidirectional Modulation of the Hedonic Value Associated with Gentle Touch | Day 1 April 21 | 114 |
| Zhang, Hantao | Cannabinoidergic Modulation of Pain-Associated Anhedonia in Mice | Day 1 April 21 | 115 |
| Zhou, Han Zhong | The Effects of Cannabidiol (CBD) and Cannibigerol (CBG), Alone and in Combination, in the Maximal Electroshock Model | Day 1 April 21 | 116 |
| Zovko, Lola | Effects of Cannabinoid Compounds on a DDD Parkinson's Model | Day 1 April 21 | 117 |
| Abi-Jaoude, Elia | A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome | Day 1 April 21 | 119 |
| Ajrawat, Prabjit | Investigating the Relationship Between Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients | Day 1 April 21 | 120 |
| Best, Laura | Endocannabinoid Metabolism as a Predictor of Risk for Alcohol Use Disorder: A PET Imaging Study with [C-11]CURB in Heavy Drinking Youth | Day 1 April 21 | 121 |
| Black, Tallan | Developmental Consequences of Gestational Cannabis Smoke Exposure: Model Validation to Preliminary Findings | Day 1 April 21 | 122 |
| Bernusky, Haley | Is Anxiety a Mediator in the Relationship Between Cannabis Use and Psychotic-like Experiences in Emerging Adults? Investigating a Mediation Model in a Multi-Site University Sample | Day 1 April 21 | 123 |
| Christiansen, April | Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review | Day 2 April 22 | 201 |
| Das, Ankita | Motivations, Perceptions, and Effects of Cannabis Use in Individuals with Mood and Anxiety Disorders | Day 2 April 22 | 202 |
| Liwono Yana, Jerry | Risk of Depressive Disorders are Associated with Medical Cananbis Authorization: A Propensity Score Matched Cohort Study | Day 2 April 22 | 203 |
| Pereira, Christina | Investigating Endocannabinoid Metabolism in Social Anxiety Disorder with the Positron Emission Tomography (PET) Tracer [11C]CURB | Day 2 April 22 | 204 |
| Poluga, Claudia | Investigating Endocannabinoid Metabolism in Brain During Abstinence from Cannabis in Cannabis Use Disorder: A PET Study with the Fatty Acid Amide Hydrolase Radioligand [11C] CURB | Day 2 April 22 | 205 |
| Shyu, Claire | Investigating Endocannabinoid Metabolism in Chronic Pain Patients with Problematic Opioid Use: A PET Study with [C-11]CURB | Day 2 April 22 | 206 |
| Sorkhou, Maryam | Effects of Extended Cannabis Abstinence on Clinical and Cognitive Outcomes in Patients with Co-Occurring Major Depression and Cannabis Use Disorder | Day 2 April 22 | 207 |
| Sultan, Alysha | The Association of CNR1 Genetic Variants with Resting-State Functional Connectivity in Youth Bipolar Disorder | Day 2 April 22 | 208 |
| Voci, Sabrina | Prevalence of Cannabis Use Among Ontarians Seeking Treatment to Quit Smoking from 2015-2021 and Association with Tobacco Cessation Outcome | Day 2 April 22 | 209 |
| Wang, Hui Jue (Janet) | Plasma 2-AG and AEA as Biomarkers of Agitation Severity and Response to Nabilone in Patients with Moderate-to-Severe Alzheimer’s Disease | Day 2 April 22 | 210 |
| Xiao, Ke Bin (Kelly) | The Concept of Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder: A Human Laboratory Study | Day 2 April 22 | 211 |
| Chanady, Tara | A photovoice Exploration of Quebec LGBTQIA+ Youth Use of Cannabis for Introspection | Day 2 April 22 | 212 |
| Lo, Lindsay | “Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations | Day 2 April 22 | 213 |
| Moebes, Zakkaery | Lower-Risk Substance Use Guidelines Accessible by Youth | Day 2 April 22 | 214 |
| Pistawka, Carly | A Clinical Framework for Evaluating Cannabis Product Quality and Safety (CQS) | Day 2 April 22 | 215 |
| Walker, Madison | How Cannabis Legalization and COVID-19 in Canada has Affected Rates of Trauma and Injury (CLARITY) | Day 2 April 22 | 216 |
| Balneaves, Lynda | Cannabis and Older Adults | Day 2 April 22 | 217 |
| Loi, Avery | Use of a Cannabis Clinical Guide by Community Pharmacists Providing Care for People Using Cannabis: An Exploratory Feasibility Study | Day 2 April 22 | 218 |
| Zaweel, Adam | Understanding Cannabis Use and Perceptions in Patients with Substance Use Disorders and Concurrent Disorders | Day 2 April 22 | 221 |
| Chhabra, Manik | A Multi-Centre, Tolerability Study of a Cannabidiol-enriched Cannabis Herbal Extract for Chronic Headaches in Adolescents: the CAN-CHA Trial Protocol | Day 2 April 22 | 222 |
| Tessa Cosman | Principal Components Analysis of the Marijuana Craving Questionnaire-Short Form: Evidence for a Two-factor Structure of General Craving and Lack of Control | Day 2 April 22 | 223 |